INSP SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 2, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 3, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 4, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 3, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 4, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Inspire Medical Systems Reports Third Quarter 2026 Financial Results and Narrows Full Year Guidance

Nov 2, 2026

8-K

Inspire Medical Systems Announces Q2 2026 Financial Results and New Strategic Growth Plan

Aug 3, 2026

8-K

Inspire Medical Systems, Inc. Appoints Michael H. Carrel to Board of Directors

Jul 24, 2026

8-K

Inspire Medical Systems Announces Retirement of Board Member Casey M. Tansey

Jul 22, 2026

8-K

Inspire Medical Systems, Inc. Releases Updated Investor Presentation

Jun 26, 2026

8-K

Inspire Medical Systems, Inc. Announces Results of 2026 Annual Meeting of Stockholders

May 5, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

1,000,000 Shares

Aug 15, 2022

424B5

1,000,000 Shares

Aug 11, 2022

424B5

2,000,000 Shares

Apr 15, 2020

424B5

Common Stock

Apr 13, 2020

424B4

2,500,000 Shares

Dec 7, 2018

424B4

6,750,000 Shares

May 4, 2018

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 7, 2026

S-3ASR

Common Stock Preferred Stock Debt Securities Warrants Purchase Contracts Units

Apr 13, 2020

S-1

2,500,000 Shares

Dec 4, 2018

DRS

Form DRS - Draft Registration Statement

Nov 20, 2018

S-8

8,783,119

May 7, 2018

FWP

6,750,000 shares

May 2, 2018

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 20, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 20, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 9, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 18, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Mar 18, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Mar 19, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

NEWSoleus Capital Master Fund, L.P. (Filed by)

Nov 9, 2026

SCHEDULE 13G/A

VANGUARD PORTFOLIO MANAGEMENT LLC (Filed by)

Oct 30, 2026

Ellis Gary Lee (Reporting)

Oct 16, 2026

Melenikiotou Georgia (Reporting)

Oct 16, 2026

CARREL MICHAEL H (Reporting)

Oct 16, 2026

Broader Shelley G (Reporting)

Oct 16, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

Jun 1, 2026

Form SD - Specialized disclosure report

May 30, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 7, 2018

CORRESP

Form CORRESP - Correspondence

Dec 4, 2018

CORRESP

Form CORRESP - Correspondence

Dec 4, 2018

LETTER

Form UPLOAD - SEC-generated letter

Dec 3, 2018

Inspire Medical Systems, Inc. INSP · SEC Filings